adcendo Revenue and Competitors
Estimated Revenue & Valuation
- adcendo's estimated annual revenue is currently $10.5M per year.
- adcendo's estimated revenue per employee is $201,000
Employee Data
- adcendo has 52 Employees.
- adcendo grew their employee count by 37% last year.
adcendo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is adcendo?
ADCendo ApS seeks to explore novel targets in development of antibody-drug conjugates, to create new anti-cancer medicine for patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. ADCendo ApS is a resident company at Bioinnovation Institute (BII).
keywords:N/A
N/A
Total Funding
52
Number of Employees
$10.5M
Revenue (est)
37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
adcendo News
2022-04-13 - Adcendo presents Data on uPARAP targeting ADCs in ...
The poster presentation highlights the preclinical evaluation of several of Adcendo´s ADC candidates for the treatment of osteosarcoma.
Other Companies in Copenhagen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.3M | 54 | -30% | N/A |
#2 | $7M | 54 | -5% | N/A |
#3 | N/A | 54 | 2% | N/A |
#4 | $14.1M | 54 | 93% | N/A |
#5 | $7.2M | 55 | -19% | N/A |